Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activationLijuan Liu(Wuhan University), Fan Zhu(Wuhan University)HepatologyMay 11, 201210.1002/hep.25834Cited by 85SaveCiteExport RISWatch citationsRelated PapersAntagonizing STAT5B dimerization with an osmium complex|Scientific Reports|2016|16Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma|Oncotarget|2017|15